Although recent studies using RSTS patient-derived cells have underlined neuronal morphological and excitability defects10, it has been difficult to decipher the molecular consequences of CBP or EP300 deficiency in the RSTS brain4,9. This evidence concerns the gene EP300 and Rubinstein-Taybi syndrome.